CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- 4 Open-market sale Chief Scientific Officer sold 1,701 shares at $47.05 ($80,032)
- 4 Grant or award Chief Accounting Officer acquired 5,750 shares (grant or award)
- 4 Exercise or conversion Chief Scientific Officer acquired 8,252 shares (option exercise)
- 4 Planned sale Chief Medical Officer sold 1,324 shares at $24.39 ($32,289)
- 4 Grant or award Director acquired 4,121 shares (grant or award)
- 4 Grant or award Director acquired 4,121 shares (grant or award)
- 4 Grant or award Director acquired 4,121 shares (grant or award)
- 4 Grant or award Director acquired 4,121 shares (grant or award)
- 4 Grant or award Director acquired 4,121 shares (grant or award)
- 4 Grant or award Director acquired 4,121 shares (grant or award)
- 4 Grant or award Director acquired 4,121 shares (grant or award)
- 4 Grant or award Director acquired 4,121 shares (grant or award)
- 4 Grant or award Director acquired 8,242 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 1,051 shares at $29.53 ($31,036)
- 4 Open-market sale President and CEO sold 5,878 shares at $29.53 ($173,577)
- 4 Open-market sale Chief Financial Officer sold 1,745 shares at $29.53 ($51,530)
- 4 Grant or award Chief Financial Officer acquired 19,125 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 19,125 shares (grant or award)
- 4 Grant or award President and CEO acquired 61,975 shares (grant or award)
Page 5 of 15 · 285 filings